{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:35:20Z","timestamp":1793900120039,"version":"4.8.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.vaccine.2024.04.051","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T15:46:38Z","timestamp":1714751198000},"page":"3486-3492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Assessment of potential adverse events following the 2022\u20132023 seasonal influenza vaccines among U.S. adults aged 65 years and older"],"prefix":"10.1016","volume":"42","author":[{"given":"Xiangyu Chianti","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2831-9315","authenticated-orcid":false,"given":"Joann F.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0792-5690","authenticated-orcid":false,"given":"Michelle","family":"Ondari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1489-0438","authenticated-orcid":false,"given":"Patricia C.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Freyria Duenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tainya C.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gita","family":"Nadimpalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0263-0343","authenticated-orcid":false,"given":"Sylvia","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8020-6839","authenticated-orcid":false,"given":"Yoganand","family":"Chillarige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Kelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Forshee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Shoaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.04.051_b0005","unstructured":"Centers for Disease Control and Prevention. Seasonal Flu Vaccines 2023 [Available from: https:\/\/www.cdc.gov\/flu\/prevent\/flushot.htm#:\u223c:text=For%20the%202022%2D2023%20flu%20season%2C%20there%20are%20three%20flu,Fluad%20Quadrivalent%20adjuvanted%20flu%20vaccine."},{"issue":"4","key":"10.1016\/j.vaccine.2024.04.051_b0010","first-page":"1601","article-title":"High clinical burden of influenza disease in adults aged \u2265 65 years: can we do better?","volume":"40","author":"Langer","year":"2023","journal-title":"A Systematic Literature Review Adv Ther"},{"key":"10.1016\/j.vaccine.2024.04.051_b0015","unstructured":"Centers for Disease Control and Prevention. Weekly Flu Vaccination Dashboard [cited 202Available from: https:\/\/www.cdc.gov\/flu\/fluvaxview\/dashboard\/vaccination-dashboard.html."},{"key":"10.1016\/j.vaccine.2024.04.051_b0020","unstructured":"Centers for Disease Control and Prevention. What Vaccines are Recommended for You [Available from: https:\/\/www.cdc.gov\/vaccines\/adults\/rec-vac\/index.html."},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.051_b0025","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/ije\/dyx149","article-title":"Encephalitis after influenza and vaccination: a nationwide population-based registry study from Norway","volume":"46","author":"Ghaderi","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2024.04.051_b0030","unstructured":"Institute for Vaccine Safety JHBoSoPH. Do Vaccines Cause Transverse Myelitis? [Available from: https:\/\/www.vaccinesafety.edu\/do-vaccines-cause-transverse-myelitis\/."},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.051_b0035","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/pds.3575","article-title":"Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barr\u00e9 syndrome, encephalitis, or anaphylaxis in the 2012\u20132013 season","volume":"23","author":"Kawai","year":"2014","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"50","key":"10.1016\/j.vaccine.2024.04.051_b0040","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1016\/j.vaccine.2013.10.031","article-title":"Evaluating the safety of influenza vaccine using a claims-based health system","volume":"31","author":"McCarthy","year":"2013","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2024.04.051_b0045","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.32571","article-title":"Risk of guillain-barr\u00e9 syndrome among older adults receiving influenza vaccine in Taiwan","volume":"5","author":"Yen","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.vaccine.2024.04.051_b0050","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/archneurol.2010.167","article-title":"Longitudinally extensive transverse myelitis following vaccination with nasal attenuated novel influenza A(H1N1) vaccine","volume":"67","author":"Akkad","year":"2010","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.vaccine.2024.04.051_b0055","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jon199664248","article-title":"Acute transverse myelitis after influenza vaccination: magnetic resonance imaging findings","volume":"6","author":"Bakshi","year":"1996","journal-title":"J Neuroimaging"},{"issue":"7","key":"10.1016\/j.vaccine.2024.04.051_b0060","first-page":"262","article-title":"Association between seasonal influenza vaccines and the increased risk of acute disseminated encephalomyelitis, estimated using the vaccine adverse event reporting system","volume":"77","author":"Fujimori","year":"2022","journal-title":"Pharmazie"},{"issue":"3","key":"10.1016\/j.vaccine.2024.04.051_b0065","first-page":"312","article-title":"Acute transverse myelitis following vaccination against H1N1 influenza: a case report","volume":"4","author":"Gui","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"issue":"11","key":"10.1016\/j.vaccine.2024.04.051_b0070","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1111\/ene.15516","article-title":"Guillain-Barr\u00e9 syndrome following influenza vaccination: a 15-year nationwide population-based case-control study","volume":"29","author":"Levison","year":"2022","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.vaccine.2024.04.051_b0075","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1128\/CVI.00307-13","article-title":"Acute disseminated encephalomyelitis following seasonal influenza vaccination in an elderly patient","volume":"20","author":"Machicado","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"50","key":"10.1016\/j.vaccine.2024.04.051_b0080","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1016\/j.vaccine.2013.10.033","article-title":"Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A\/H1N1 (H1N1pdm09) vaccine","volume":"31","author":"Rouleau","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.051_b0085","doi-asserted-by":"crossref","unstructured":"Petersen I, Douglas I, Whitaker H. Self controlled case series methods: an alternative to standard epidemiological study designs. 2016;354:i4515.","DOI":"10.1136\/bmj.i4515"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.051_b0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/pds.4349","article-title":"The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: a vaccine safety datalink study","volume":"27","author":"Daley","year":"2018","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.051_b0095","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/pds.3908","article-title":"Prospective influenza vaccine safety surveillance using fresh data in the sentinel system","volume":"25","author":"Yih","year":"2016","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.vaccine.2024.04.051_b0100","unstructured":"Food and Drug Administration. Master Protocol: Assessment of the Risk of Adverse Events Following Influenza Vaccinations Approved during the 2022-2023 Influenza Season 2023 [cited 2023. Available from: https:\/\/bestinitiative.org\/wp-content\/uploads\/2023\/06\/BEST_2022-2023_Influenza-AE_Protocol_2023.pdf."},{"issue":"11","key":"10.1016\/j.vaccine.2024.04.051_b0105","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/cid\/ciw607","article-title":"Acute demyelinating events following vaccines: a case-centered analysis","volume":"63","author":"Baxter","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2024.04.051_b0110","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1001\/jamainternmed.2021.6227","article-title":"Risk of guillain-barr\u00e9 syndrome following recombinant zoster vaccine in medicare beneficiaries","volume":"181","author":"Goud","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1016\/j.vaccine.2024.04.051_b0115","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jama.2021.1967","article-title":"Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US\u2014December 14, 2020-January 18, 2021","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.051_b0120","doi-asserted-by":"crossref","DOI":"10.1097\/CND.0b013e3181aaa968","article-title":"Guillain-Barr\u00e9 syndrome after vaccination in United States: data from the centers for disease control and prevention\/food and drug administration vaccine adverse event reporting system (1990\u20132005)","volume":"11","author":"Souayah","year":"2009","journal-title":"J Clin Neuromuscul Dis"},{"issue":"494","key":"10.1016\/j.vaccine.2024.04.051_b0125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1198\/jasa.2011.ap10108","article-title":"Self-Controlled case series analysis with event-dependent observation periods","volume":"106","author":"Farrington","year":"2011","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"10.1016\/j.vaccine.2024.04.051_b0130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.26579","article-title":"Seasonal variation in neurologic hospitalizations in the United States","volume":"93","author":"Hamedani","year":"2023","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.051_b0135","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaci.2009.02.035","article-title":"Anaphylaxis in olmsted county: seasonal pattern and suggestions for epidemiologic analysis","volume":"123","author":"Mulla","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"38","key":"10.1016\/j.vaccine.2024.04.051_b0140","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1016\/j.vaccine.2021.08.004","article-title":"ICD-10 anaphylaxis algorithm and the estimate of vaccine-attributable anaphylaxis incidence in Medicare","volume":"39","author":"Goud","year":"2021","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.vaccine.2024.04.051_b0145","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1016\/j.vaccine.2019.08.045","article-title":"Surveillance for guillain-barr\u00e9 syndrome after 2015\u20132016 and 2016\u20132017 influenza vaccination of medicare beneficiaries","volume":"37","author":"Arya","year":"2019","journal-title":"Vaccine"},{"issue":"394","key":"10.1016\/j.vaccine.2024.04.051_b0150","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/01621459.1986.10478280","article-title":"Multiple imputation for interval estimation from simple random samples with ignorable nonresponse","volume":"81","author":"Rubin","year":"1986","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.051_b0155","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4168\/aair.2020.12.2.359","article-title":"Delayed-Onset anaphylaxis caused by ige response to influenza vaccination","volume":"12","author":"Kim","year":"2020","journal-title":"Allergy Asthma Immunol Res"},{"issue":"3","key":"10.1016\/j.vaccine.2024.04.051_b0160","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults","volume":"137","author":"McNeil","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2024.04.051_b0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s40521-019-00215-0","article-title":"Vaccine-Associated anaphylaxis","volume":"6","author":"McNeil","year":"2019","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.vaccine.2024.04.051_b0170","article-title":"Extensive longitudinal transverse myelitis after influenza A virus infection in a patient with systemic lupus erythematosus","volume":"2022","author":"M\u00e1rquez","year":"2022","journal-title":"Case Rep Rheumatol"},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.051_b0175","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/irv.12470","article-title":"The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection","volume":"11","author":"Sellers","year":"2017","journal-title":"Influenza Other Respir Viruses"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.051_b0180","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1086\/594124","article-title":"Guillain-Barr\u00e9 syndrome and influenza virus infection","volume":"48","author":"Sivadon-Tardy","year":"2009","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2400478X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2400478X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T16:56:23Z","timestamp":1716828983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2400478X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":36,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0264410X2400478X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.051","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.09.20.23295817","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of potential adverse events following the 2022\u20132023 seasonal influenza vaccines among U.S. adults aged 65 years and older","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}